Setting Specifications - 4th Annual Conference
28th November 2012 — 29th November 2012

Critical regulatory updates and real-life industry case studies demonstrating the latest developments in analytical practices for setting specifications

Hot topics to be covered include:

• Latest updates for the forthcoming ICHQ3d guideline and how this will impact setting specifications for genotoxic impurities
• Regulatory expectations for ICHQ6A from the perspective of the MHRA, FDA and other influential European Authorities
• The latest developments in setting specifications for inhalation products, nasal sprays and topical drugs
• Understanding the risk-based approach to setting speicifications and how to implement it effectively
• Overcoming the challenges of setting specifications for oligonucleotides

Speaker Panel

Dr Abigail Moran
Deputy Manager and Pharmaceutical Assessor
MHRA, UK

Dr David Elder
Product Development Director
GlaxoSmithKline, UK

Expected Number of Attendees

NA

View Conference Website: Setting Specifications - 4th Annual Conference

Price of Attendance

n/a

Brochure

View Event Brochure

Location

Radisson Blu Hotel
Berlin
Berlin
Germany
Berlin